The sort of thing, in other words, that can make an enormous difference if policymakers get it right.
Broadly, the countries that saw the biggest rises in house prices also saw the biggest drops in saving.In short, a good part of the rising imbalances of the past few years can be explained by a series of investment busts after periods of overinvestment and sharp differences in the way policymakers responded to them.
Health inequalities were perceived by most policymakers as differences in life-expectancy between population with economic, social and geographical differences.
Regarding differences in weights between stakeholder groups, policymakers weighted the criteria 'Budget impact' and 'Relevance and validity of evidence' higher (+0.013 and +0.008, respectively) compared to all participants; they reported a lower relative weight for 'Type of medical service' (−0.011) and 'Severity of disease' (−0.008) (Additional file 2: Figure S1).
Those lacunae may provide interesting indications (in the vein of what mentioned above) as to the difference in perception between policymakers level and those who are in charge of policy research in academic centres and have easier, more accurate and more complete access to current literature on the related subjects.
In our view, the observed weak and statistically non-significant bias-adjusted correlation, with a quite tight confidence interval around this null result, provides increased support to policymakers that individual differences in PA may not be a key determinant of unhealthy weight gain in children.
In fact, better understanding of relative differences in financing of health services will help guide policymakers as to how best to deliver them.
This paper examines emerging technologies and recent research on population differences in pharmacogenomics and the perspectives of scientists, community advocates, policymakers, and social critics on the use of race as a proxy for genetic variation.
39 40 In addition, our results may have implications for policymakers given the ongoing scrutiny of differences in regulatory standards between drugs and devices.
Scientists identify a cultural gap between them and policymakers, suggesting that we need to overcome differences in the languages used to communicate findings, the timescales to produce recommendations, and the incentives to engage.
